https://www.selleckchem.com/pr....oducts/telratolimod.
AIMS To evaluate the clinical utility of first and second trimester prenatal screening biomarkers for early pregnancy prediction of gestational diabetes mellitus (GDM) risk in nulliparous women METHODS We conducted a population-based cohort study of nulliparous women participating in the California Prenatal Screening Program from 2009-2011 (n=105,379). GDM was ascertained from hospital discharge records or birth certificates. Models including maternal characteristics and prenatal screening biomarkers were developed and validated. R
Like
Comment
Share
